Monograph System Challenges Underscored By Pediatric Cold Debate
This article was originally published in The Tan Sheet
Executive Summary
Concerns about the safety and efficacy of nonprescription pediatric cough/cold products point to the need to re-examine the monograph system in the future, according to University of Florida pharmacy and pediatrics professor Leslie Hendeles, Pharm.D
You may also be interested in...
Patient Symptoms Are Better Measure Of Decongestant’s Efficacy – FDA
The patient self-assessed nasal congestion symptom score, not nasal air resistance, is the preferred tool to evaluate the effectiveness of an oral nasal decongestant such as phenylephrine, according to a report by a division of FDA's Office of New Drugs
Patient Symptoms Are Better Measure Of Decongestant’s Efficacy – FDA
The patient self-assessed nasal congestion symptom score, not nasal air resistance, is the preferred tool to evaluate the effectiveness of an oral nasal decongestant such as phenylephrine, according to a report by a division of FDA's Office of New Drugs
Patient Symptoms Are Better Measure Of Decongestant’s Efficacy – FDA
The patient self-assessed nasal congestion symptom score, not nasal air resistance, is the preferred tool to evaluate the effectiveness of an oral nasal decongestant such as phenylephrine, according to a report by a division of FDA's Office of New Drugs